Glucaric acid

Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Glucaric acid?

Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Glucaric acid

MeSH term MeSH ID Detail
Arthritis, Rheumatoid D001172 3 associated lipids
Liver Diseases D008107 31 associated lipids
Occupational Diseases D009784 42 associated lipids
Kidney Diseases D007674 29 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Leukemia P388 D007941 43 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Myocardial Infarction D009203 21 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Hyperplasia D006965 34 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Myocardial Ischemia D017202 11 associated lipids
Alcoholism D000437 27 associated lipids
Hypocalcemia D006996 12 associated lipids
Brain Ischemia D002545 89 associated lipids
Epilepsy D004827 35 associated lipids
Testicular Neoplasms D013736 5 associated lipids
Myocardial Reperfusion Injury D015428 20 associated lipids
Per page 10 20 50 100 | Total 85

PubChem Associated disorders and diseases

What pathways are associated with Glucaric acid

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Glucaric acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Glucaric acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Glucaric acid?

There are no associated biomedical information in the current reference collection.

What genes are associated with Glucaric acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Glucaric acid?

Knock-out

Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Glucaric acid

Download all related citations
Per page 10 20 50 100 | Total 1061
Authors Title Published Journal PubMed Link
Ozdemir A et al. Relationship between iron replacement and hepatic functions in hepatitis C virus-positive chronic haemodialysis patients. 2005 Nephrology (Carlton) pmid:16221090
Ayotte P et al. Biomarker measurements in a coastal fish-eating population environmentally exposed to organochlorines. 2005 Environ. Health Perspect. pmid:16203240
St Peter WL et al. Trends in intravenous iron use among dialysis patients in the United States (1994-2002). 2005 Am. J. Kidney Dis. pmid:16183420
Strolin Benedetti M et al. Induction of endogenous pathways by antiepileptics and clinical implications. 2005 Fundam Clin Pharmacol pmid:16176329
Erichsen K et al. Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease. 2005 Scand. J. Gastroenterol. pmid:16165718
Zager RA Parenteral iron treatment induces MCP-1 accumulation in plasma, normal kidneys, and in experimental nephropathy. 2005 Kidney Int. pmid:16164630
Perek N et al. MRP-1 protein expression and glutathione content of in vitro tumor cell lines derived from human glioma carcinoma U-87-MG do not interact with 99mTc-glucarate uptake. 2005 Cancer Biother. Radiopharm. pmid:16114987
Macdougall IC and Roche A Administration of intravenous iron sucrose as a 2-minute push to CKD patients: a prospective evaluation of 2,297 injections. 2005 Am. J. Kidney Dis. pmid:16112047
Wood DM et al. Hepatocellular damage following therapeutic intravenous iron sucrose infusion in a child. 2005 Ther Drug Monit pmid:16044093
Bontchev RP and Moore RC Crystal structure and aqueous solubility of ammonium D-glucarate. 2005 Carbohydr. Res. pmid:16043161
Sanai T et al. Effect of saccharated ferric oxide and iron dextran on the metabolism of phosphorus in rats. 2005 J. Lab. Clin. Med. pmid:16025088
Agarwal R Ironing out the mystery of nephrotoxicity of parenteral iron. 2005 J. Lab. Clin. Med. pmid:16025083
pmid:16006090
Keven K et al. Combination of intravenous iron sucrose and ascorbic acid in hemodialysis patients. 2005 Kidney Int. pmid:15954940
Schmittgen TD et al. Effects of 5-fluorouracil, leucovorin, and glucarate in rat colon-tumor explants. 1992 Cancer Chemother. Pharmacol. pmid:1586977
pmid:15855210
pmid:15795917
Cuenca J et al. Role of parenteral iron in the management of anaemia in the elderly patient undergoing displaced subcapital hip fracture repair: preliminary data. 2005 Arch Orthop Trauma Surg pmid:15789233
pmid:15754533
pmid:15745425
Pecharki GD et al. Effect of sucrose containing iron (II) on dental biofilm and enamel demineralization in situ. 2005 Mar-Apr Caries Res. pmid:15741724
Liu Y and Reineke TM Hydroxyl stereochemistry and amine number within poly(glycoamidoamine)s affect intracellular DNA delivery. 2005 J. Am. Chem. Soc. pmid:15740138
Sheashaa H et al. Parenteral iron therapy in treatment of anemia in end-stage renal disease patients: a comparative study between iron saccharate and gluconate. 2005 Nephron Clin Pract pmid:15692217
Ogi M et al. [Comparison of intravenous ascorbic acid versus intravenous iron for functional iron deficiency in hemodialysis patients]. 2004 Nihon Jinzo Gakkai Shi pmid:15645737
Guz G et al. Elevated cardiac troponin T in hemodialysis patients receiving more intravenous iron sucrose. 2004 Ren Fail pmid:15600258
Kanamaru R and Wakui A [Pharmacokinetic studies on fluorinated pyrimidine in cancer cell and tissue]. 1992 Gan To Kagaku Ryoho pmid:1558391
Tutor-Crespo M et al. Isoforms of serum gamma-glutamyltransferase in epileptic patients treated with enzyme-inducing anticonvulsant drugs. 2004 J Pharm Pharm Sci pmid:15576017
Borawski J et al. Endothelial injury markers with high-dose intravenous iron therapy in renal failure. 2004 Clin. Appl. Thromb. Hemost. pmid:15497030
Agarwal R On the nature of proteinuria with acute renal injury in patients with chronic kidney disease. 2005 Am. J. Physiol. Renal Physiol. pmid:15467003
Wada S et al. [Study of preventive effect of 1-hexylcarbamoyl-5-fluorouracil (HCFU) or combination of HCFU and 2.5-di-O-acetyl-D-glucaro (1-4) (6-3) dilactone (SLA) after preservative operation against bladder cancer]. 1992 Hinyokika Kiyo pmid:1546564
Mustajoki P et al. Rapid normalization of antipyrine oxidation by heme in variegate porphyria. 1992 Clin. Pharmacol. Ther. pmid:1544288
Cuenca J et al. Patients with pertrochanteric hip fracture may benefit from preoperative intravenous iron therapy: a pilot study. 2004 Transfusion pmid:15383017
Dornyei A et al. Vanadium(IV,V) complexes of D-saccharic and mucic acids in aqueous solution. 2004 Dalton Trans pmid:15381996
pmid:15373973
pmid:15371980
Leijn E et al. Intravenous iron supplementation in children on hemodialysis. 2004 May-Jun J. Nephrol. pmid:15365964
Tiranathanagul K et al. Oxidative stress from rapid versus slow intravenous iron replacement in haemodialysis patients. 2004 Nephrology (Carlton) pmid:15363053
Schwenk MH and Blaustein DA Rapid, high-dose intravenous iron sucrose therapy in 2 Jehovah's Witness patients with severe anemia, iron deficiency and chronic kidney disease. 2004 Clin. Nephrol. pmid:15356968
McMahon LP et al. Effects of different dialysis membranes on serum concentrations of epoetin alfa, darbepoetin alfa, enoxaparin, and iron sucrose during dialysis. 2004 Am. J. Kidney Dis. pmid:15332224
Aronoff GR et al. Iron sucrose in hemodialysis patients: safety of replacement and maintenance regimens. 2004 Kidney Int. pmid:15327417
Agarwal R Transferrin saturation with intravenous irons: an in vitro study. 2004 Kidney Int. pmid:15327409
Tutor-Crespo MJ et al. Possible induction of cholinesterase in epileptic patients treated with anticonvulsant drugs: relationship with lipoprotein levels. 2004 J Clin Pharmacol pmid:15317825
Schröder O et al. A study for the evaluation of safety and tolerability of intravenous high-dose iron sucrose in patients with iron deficiency anemia due to gastrointestinal bleeding. 2004 Z Gastroenterol pmid:15314711
Liu Z et al. High-resolution imaging with (99m)Tc-glucarate for assessing myocardial injury in rat heart models exposed to different durations of ischemia with reperfusion. 2004 J. Nucl. Med. pmid:15235074
Pak KY et al. Labeling and stability of radiolabeled antibody fragments by a direct 99mTc-labeling method. 1992 Int J Rad Appl Instrum B pmid:1522021
Liu Z et al. 99mTc glucarate high-resolution imaging of drug sensitive and drug resistant human breast cancer xenografts in SCID mice. 2004 Nucl Med Commun pmid:15208499
Sengoelge G et al. Dose-dependent effect of parenteral iron therapy on bleomycin-detectable iron in immune apheresis patients. 2004 Kidney Int. pmid:15200437
Zager RA et al. Parenteral iron nephrotoxicity: potential mechanisms and consequences. 2004 Kidney Int. pmid:15200421
Liu Y et al. New poly(d-glucaramidoamine)s induce DNA nanoparticle formation and efficient gene delivery into mammalian cells. 2004 J. Am. Chem. Soc. pmid:15198572
Oredipe OA et al. Dietary glucarate-mediated inhibition of initiation of diethylnitrosamine-induced hepatocarcinogenesis. 1992 Toxicology pmid:1519243